Financial reports
10-Q
2023 Q3
Quarterly report
1 Nov 23
10-Q
2023 Q2
Quarterly report
2 Aug 23
10-Q
2023 Q1
Quarterly report
27 Apr 23
ARS
2022 FY
Annual report to shareholders
18 Apr 23
10-K
2022 FY
Annual report
15 Feb 23
10-Q
2022 Q3
Quarterly report
27 Oct 22
10-Q
2022 Q2
Quarterly report
28 Jul 22
10-Q
2022 Q1
Quarterly report
28 Apr 22
10-K
2021 FY
Annual report
9 Feb 22
10-Q
2021 Q3
Quarterly report
28 Oct 21
Current reports
8-K
Completion of Acquisition or Disposition of Assets
14 Dec 23
8-K
Other Events
12 Dec 23
8-K
Seagen Third Quarter 2023 Financial Results Reflect Strong Product Sales Growth, and Significant Portfolio and Pipeline Progress
1 Nov 23
8-K
Other Events
19 Oct 23
8-K
Significantly Improve Overall Survival and Progression-Free Survival in Patients With Previously Untreated Advanced Bladder Cancer in Pivotal
22 Sep 23
8-K
Improved Overall Survival in Patients With Recurrent or Metastatic Cervical Cancer Compared With Chemotherapy Alone
5 Sep 23
8-K
Other Events
16 Aug 23
8-K
Results of Operations and Financial Condition
2 Aug 23
8-K
Other Events
14 Jul 23
8-K
Other Events
14 Jun 23
Registration and prospectus
15-12G
Securities registration termination
26 Dec 23
S-8 POS
Registration of securities for employees (post-effective amendment)
14 Dec 23
S-8 POS
Registration of securities for employees (post-effective amendment)
14 Dec 23
S-8 POS
Registration of securities for employees (post-effective amendment)
14 Dec 23
S-8 POS
Registration of securities for employees (post-effective amendment)
14 Dec 23
S-8 POS
Registration of securities for employees (post-effective amendment)
14 Dec 23
S-8 POS
Registration of securities for employees (post-effective amendment)
14 Dec 23
S-8 POS
Registration of securities for employees (post-effective amendment)
14 Dec 23
S-8 POS
Registration of securities for employees (post-effective amendment)
14 Dec 23
S-8 POS
Registration of securities for employees (post-effective amendment)
14 Dec 23
Proxies
DEFA14A
Additional proxy soliciting materials
23 May 23
DEFA14A
Additional proxy soliciting materials
15 May 23
DEFA14A
Additional proxy soliciting materials
1 May 23
DEFM14A
Proxy related to merger
24 Apr 23
DEFA14A
Additional proxy soliciting materials
18 Apr 23
DEF 14A
Definitive proxy
18 Apr 23
PREM14A
Preliminary proxy related to merger
14 Apr 23
DEFA14A
Additional proxy soliciting materials
13 Mar 23
DEFA14A
Additional proxy soliciting materials
13 Mar 23
DEFA14A
Additional proxy soliciting materials
13 Mar 23
Other
CT ORDER
Confidential treatment order
18 Nov 22
SEC STAFF
SEC staff action: Order
29 Mar 21
SEC STAFF
SEC staff action: Order
1 Mar 21
CT ORDER
Confidential treatment order
24 Aug 20
CT ORDER
Confidential treatment order
13 Apr 20
SEC STAFF
SEC staff action: Order
18 Feb 20
CT ORDER
Confidential treatment order
6 Feb 20
SEC STAFF
SEC staff action: Order
6 Feb 20
CT ORDER
Confidential treatment order
28 Jan 20
CT ORDER
Confidential treatment order
28 Jan 20